Application of walnut tree sawdust modified with KMnO4 for removal of methylene blue from aqueous solution in batch system: Isotherm, kinetic and thermodynamic studies

94-101In this study, the adsorption of methylene blue from aqueous solution by modifying sawdust with KMnO4 has been studied as an effective adsorbent. The surface and characteristics of the composite are studied by Scanning electron microscopy (SEM), X-ray diffraction (XRD) and Fourier transform infrared spectroscopy (FTIR). The result demonstrate, that by increasing pH, the amount of methylene blue adsorption also increases, and the amount of optimum removal of this dye (96.36%) was obtained at methylene blue dye pH aqueous solution equal to 6 with initial concentration 100 mg L-1. The studies have shown that the kinetics of the adsorption process follows the pseudo-second-order model with a correlation coefficient R2>0.999, and equilibrium data conform the Langmuir isotherm model with R2>0.9982 and a maximum capacity of single layer adsorption qe equal to 100 mgg-1. Thermodynamically, the reaction is endothermic and spontaneous. Consequently, the result has shown, that the modified sawdust can be used as a quick, inexpensive and effective adsorbent in order for removal of methylene blue dye from aqueous solution

Application of walnut tree sawdust modified with KMnO4 for removal of methylene blue from aqueous solution in batch system: Isotherm, kinetic and thermodynamic studies

In this study, the adsorption of methylene blue from aqueous solution by modifying sawdust with KMnO4 has been studied as an effective adsorbent. The surface and characteristics of the composite are studied by Scanning electron microscopy (SEM), X-ray diffraction (XRD) and Fourier transform infrared spectroscopy (FTIR). The result demonstrate, that by increasing pH, the amount of methylene blue adsorption also increases, and the amount of optimum removal of this dye (96.36%) was obtained at methylene blue dye pH aqueous solution equal to 6 with initial concentration 100 mg L-1. The studies have shown that the kinetics of the adsorption process follows the pseudo-second-order model with a correlation coefficient R2>0.999, and equilibrium data conform the Langmuir isotherm model with R2>0.9982 and a maximum capacity of single layer adsorption qe equal to 100 mgg-1. Thermodynamically, the reaction is endothermic and spontaneous. Consequently, the result has shown, that the modified sawdust can be used as a quick, inexpensive and effective adsorbent in order for removal of methylene blue dye from aqueous solution

Direct Monitoring of Verapamil Level in Exhaled Breath Condensate Samples

Background: In this research, an enhanced fluorimetric assay was developed for the direct monitoring of verapamil in exhaled breath condensate (EBC). The method is based on a binding–induced rigidity inside the sodium dodecyl sulfate (SDS) micelle which eliminate collisional quenching and vibrational modes responsible for non-radiative decay. This process produces an enhancement in the emission intensity of verapamil. Methods: Fluorescence intensity measurements were made at 15 ˚C on a FP-750 spectrofluorometer with maximum excitation and emission wavelengths of 280 nm and 310 nm, respectively. The important parameters influencing the analytical signal in experimental steps were investigated and optimized. The method was validated with considering of the linearity, recovery and limit of detection. Results: Under the optimized experimental conditions, the calibration graph was linear in the range of 0.02 − 12.0 µg.mL−1 of verapamil with a detection limit of 0.008 µg.mL–1. Conclusion: The proposed method was found to be suitable and accurate for the determination of verapamil and the validated method was successfully used for analysis of verapamil in EBC of patients receiving verapamil with the satisfactory results

A Simple Colorimetric Method for Determination of Ethanol in Exhaled Breath Condensate

Background: Ethanol is considered as a toxic compound when used in excess amounts. The toxic concentration for ethanol was reported to be 1000 – 2000 μg.mL-1 in plasma and serum samples. The aim of the current study was to develop a rapid and catalyst free colorimetric method for determination of ethanol in exhaled breath condensate (EBC) sample. Methods: A redox reaction with dichromate-based colorimetric method was used for determination of ethanol in EBC. Results: The proposed method shows a good sensitivity and selectivity for ethanol in compared with other compounds and biomarkers existing in EBC. The color change can be easily observed by the naked eye in the presence of ethanol in the range of 300 - 8000 μg.mL-1. The quantitative detection of ethanol was fully validated and used for determination of ethanol in EBC of alcohol administrated individuals. Conclusion: This catalyst free colorimetric method has great potential for ethanol determination owing to many desirable properties such as high reliability, high sensitivity, and fast response time

Clinical considerations on monkeypox antiviral medications: An overview

Abstract Monkeypox (mpox), a virus belonging to the orthopoxvirus family, can cause a zoonotic infectious disease with morbidity and cosmetic complications. Therefore, effective antiviral drugs with appropriate safety profiles are important for the treatment of patients with mpox. To date, there is no FDA‐approved drug for the treatment of mpox. However, tecovirimat, brincidofovir, and cidofovir are the candidate therapies for the management of mpox. Given the safety concerns following the use of these medications, we aimed to review evidence on the clinical considerations of mpox antiviral medications that will be useful to guide clinicians in the treatment approach. Based on the current evidence, tecovirimat has favorable clinical efficacy, safety, and side effect profile and it can be considered as first‐line treatment for mpox

New‐onset systemic lupus erythematosus after BBIBP‐CorV vaccination

Key Clinical Message While reports of new‐onset systemic lupus erythematosus (SLE) after mRNA‐based COVID‐19 vaccines exist, no such reports have been documented following inactivated vaccines. We describe a case of SLE after receiving the BBIBP‐CorV vaccine. The patient exhibited characteristic SLE criteria, indicating a possible association between the inactivated vaccine and new‐onset SLE